ASI 2017*
Chairs: Michele Teng & Connie Jackaman
Impact of elevated sympathetic neural signaling on anti-cancer immunity and immunotherapy (#29)
2:10 PM
Efficacy of neoadjuvant immunotherapy is mediated through the selective expansion of tumour-specific CD8+ T cells with a memory precursor phenotype (#30)
2:25 PM
The Complement C3a Receptor: a Novel Therapeutic Target for Melanoma? (#31)
2:40 PM
TACI deletion ameliorates immune dysfunction in Chronic Lymphocytic Leukaemia (#32)
2:55 PM
A multifunctional role for adjuvant anti-4-1BB therapy in augmenting anti-tumour responses by chimeric antigen receptor T cells (#33)
3:10 PM
Targeting the tumour microenvironment to enhance immunotherapy against cancer (#34)
3:25 PM
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity (#35)
3:40 PM